Skip to main content

Advertisement

Log in

Effects of different branched-chain amino acids supplementation protocols on the inflammatory response of LPS-stimulated RAW 264.7 macrophages

  • Original Article
  • Published:
Amino Acids Aims and scope Submit manuscript

Abstract

Although branched-chain amino acids (BCAA) are commonly used as a strategy to recover nutritional status of critically ill patients, recent findings on their role as immunonutrients have been associated with unfavorable outcomes, especially in obese patients. The present study aimed to explore the effects of different BCAA supplementation protocols in the inflammatory response of LPS-stimulated RAW 264.7 macrophages. Cell cultures were divided into five groups, with and without BCAA supplementation, (2 mmol/L of each amino acid). Then, cell cultures followed three different treatment protocols, consisting of a pretreatment (PT), an acute treatment (AT), and a chronic treatment (CT) with BCAA and LPS stimulation (1 µg/mL). Cell viability was analyzed by MTT assay, NO production was assessed by the Griess reaction and IL-6, IL-10, TNF-α and PGE2 synthesis, was evaluated by ELISA. BCAA significantly increased cell viability in AT and CT protocols, and NO and IL-10 synthesis in all treatment protocols. IL-6 synthesis was only increased in PT and CT protocols. TNF-α and PGE2 synthesis were not altered in any of the protocols and groups. BCAA supplementation was able to increase both pro and anti-inflammatory mediators synthesis by RAW 264.7 macrophages, which was influenced by the protocol applied. Moreover, these parameters were significantly increased by isoleucine supplementation, highlighting a potential research field for future studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

Availability of data and materials

This study is based on the thesis of Andrea Bonvini, openly available in Biblioteca Digital-USP at https://doi.org/10.11606/T.9.2019.tde-26082019-112844.

Code availability

Not applicable.

Abbreviations

AT:

Acute treatment

CAT1:

Cationic amino acid transporter

COX-2:

Cyclooxygenase 2

CT:

Chronic treatment

CTL:

Control group

DMEM:

Dulbecco’s modified Eagle’s medium

DMEM-S:

Dulbecco’s modified Eagle’s medium with BCAA supplementation

DMSO:

Dimethyl sulfoxide

ELISA:

Enzyme-linked immunosorbent assay

FBS:

Fetal bovine serum

IFNs:

Type I interferons

IL:

Interleukins

ILE:

Isoleucine group

iNOS:

Inducible nitric oxide synthase

LEU:

Leucine group

LPS:

Lipopolysaccharide

mTOR:

Mammalian target of rapamycin

MTT:

(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium

NADH:

Nicotinamide adenine dinucleotide

NADPH:

Nicotinamide adenine dinucleotide phosphate

NF-kB:

Nuclear factor kappa-B

NO:

Nitric oxide

PT:

Pretreatment

SIRS:

Systemic inflammatory response syndrome

T2D:

Type 2 diabetes

TCA:

Tricarboxylic acid cycle

TLR4:

Toll-like receptor 4

TNF- α:

Tumor necrosis factor-alpha

TSC1:

Tuberous sclerosis complex 1

VAL:

Valine group

References

Download references

Funding

This research was funded by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), grant numbers 2016/04910-0 and 2016/11360-6.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: Andrea Bonvini and Marcelo Macedo Rogero; methodology: Andrea Bonvini, Leonardo Mendes Bella, Primavera Borelli and Ricardo Ambrosio Fock; software: Andrea Bonvini, Audrey Yule Coqueiro and Leonardo Mendes Bella, formal analysis: Andrea Bonvini and Leonardo Mendes Bella; writing—original draft preparation, Andrea Bonvinii and Marcelo Macedo Rogero; writing—review and editing: Andrea Bonvini, Marcelo Macedo Rogero, Audrey Yule Coqueiro, Raquel Raizel, Leonardo Mendes Bella, Primavera Borelli, Ricardo Ambrosio Fock and Julio Tirapegui; Supervision: Marcelo Macedo Rogero, Primavera Borelli, Ricardo Ambrosio Fock and Julio Tirapegui; funding acquisition: Andrea Bonvini, Audrey Yule Coqueiro and Julio Tirapegui.

Corresponding author

Correspondence to Andrea Bonvini.

Ethics declarations

Conflicts of interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Ethics approval

Not applicable.

Informed consent

Not applicable.

Research involving human participants and/or animals

Not applicable.

Additional information

Handling Editor: E. Closs.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bonvini, A., Rogero, M.M., Coqueiro, A.Y. et al. Effects of different branched-chain amino acids supplementation protocols on the inflammatory response of LPS-stimulated RAW 264.7 macrophages. Amino Acids 53, 597–607 (2021). https://doi.org/10.1007/s00726-021-02940-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00726-021-02940-w

Keywords

Profiles

  1. Marcelo Macedo Rogero